Fatigue
921
78
108
578
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
111 trials with published results (12%)
Research Maturity
578 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.4%
50 terminated out of 921 trials
92.0%
+5.5% vs benchmark
8%
74 trials in Phase 3/4
19%
111 of 578 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 578 completed trials
Clinical Trials (921)
Patient-Centered Assessment of Symptoms and Outcomes
Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis
Lupus Intervention for Fatigue Trial
Self-Selected Music and Anaerobic Performance in Futsal Players During Ramadan
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
Neuromodulation and Fatigue
Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE
Effect of Aerobic Exercise Training on Cardiorespiratory Function in Patients With Traumatic Brain Injury
A Naturalistic Trial of the Norwegian Sickness Absence Clinic. The NSAC Efficacy Study
Healthy Lifestyles After Cancer for Adolescents and Young Adults: A Program to Reduce Cardiovascular Risk Factors
The Effect of Remotely Delivered Pilates on Physical , and Psychological Outcomes in Individuals With Multiple Sclerosis
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
The Effects of Chiropractic on Cancer-related Fatigue
Effects of Transcutaneous Vagus Nerve Stimulation on Recovery
Exploring Biological Markers of Driver Fatigue for Enhanced Road Safety
The Effects of Apathy on Different Forms of Fatigue
Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer
MitoQ for Fatigue in Multiple Sclerosis (MS)
Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments